ISAR SMART-2 - ISAR SMART-2

Description:

The goal of the ISAR SMART-2 trial was to evaluate whether: 1) placement of phosphorylcholine (PC)-coated stents is associated with a reduction in restenosis in small coronary arteries compared with percutaneous transluminal coronary angioplasty (PTCA); and 2) whether the administration of abciximab compared with placebo is associated with a reduction in restenosis after interventions in patients with small coronary arteries undergoing percutaneous coronary intervention (PCI).